Synthesis and characterization of compounds 2a-d

Synthesis of Pd-labile masking groups
Synthesis of propargyloxybenzyl alcohol derivatives. Potassium carbonate (4.7 g) was added to a solution of o-hydroxybenzyl alcohol or p-hydroxybenzyl alcohol (2.5 g) dissolved in acetonitrile (50 mL).
After stirring at room temperature for 1 h, the mixture was treated dropwise with propargyl bromide (2.93 mL as 80 % (v/v) in toluene) and heated to reflux for 48 h. The solution was then filtered, concentrated in vacuo, and the crude was purified via flash chromatography (30 % ethyl acetate in hexane).
p-Propargyloxybenzyl alcohol. The synthetic method described using phydroxybenzyl alcohol gave a viscous bright yellow liquid (3.7 g, 99 %). Rf 
Synthesis of p-nitrophenyl carbonate derivatives. A solution of 4-nitrophenylchloroformate (0.48 g)
in dry DCM (8 mL) was added dropwise to a solution of the alcohol (2.2 mmol) and pyridine (0.19 mL) in DCM (8 mL) at 0 °C under nitrogen in the dark. The mixture was stirred from 0 °C to room temperature overnight and monitored by to indicate full consumption of the alcohol (at approx. 20 h). After concentrating in vacuo, the crude residue was re-dissolved in ethyl acetate (70 mL), washed with H2O (2 x 50 mL) and brine (2 x 50 mL), dried over MgSO4 and re-concentrated in vacuo, and the crude was purified via flash chromatography (50 % DCM in hexane).
p-Nitrophenyl propargyl carbonate. The synthetic method described using propargyl alcohol gave white crystals (0.31 g, 64 %). Rf = 0.29 (50 % DCM in hexane). 1 
Synthesis of compounds 2a-d
General Procedure. A solution of the corresponding alkyl p-nitrophenyl carbonate (55.2 μmol) in anhydrous DMF (2 mL) was flushed with nitrogen after stirring for 10 min, then syringed into a flask containing a solution of doxorubicin HCl (20 mg) and triethylamine (7.5 μL) in anhydrous DMF under nitrogen at room temperature. The reaction was monitored by TLC (10 % methanol in DCM) to observe complete consumption of doxorubicin. After 20 h, the reaction was diluted with H2O (50 mL) and extracted with ethyl acetate (4 x 50 mL). The combined organic extracts were concentrated down to a volume of ~100 mL, then washed successively with saturated NaHCO3 (2 x 50 mL), H2O (2 x 50 mL) and brine (2 x 50 mL), dried over MgSO4, concentrated in vacuo with the water bath kept below 40 °C and the crude was purified via flash chromatography (0 2 % methanol in DCM). 0  10  20  30  40  50  60  70  80  90  100  110  120  130  140  150  160  170  180  190  200  210  220 f1 ( 0  10  20  30  40  50  60  70  80  90  100  110  120  130  140  150  160  170  180  190  200  210  220 f1 ( 
N-Propargyloxycarbonyl doxorubicin (2a
Scanning Electron Microscopy imaging
SEM images were performed at the School of Biological Sciences of the University of Edinburgh.
Samples were fixed in a solution of 3 % glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.3) for 2 h, then washed in 3 x 10 min changes of 0.1 M sodium cacodylate buffer. Samples were then fixed in 1 % osmium tetroxide in 0.1 M sodium cacodylate buffer for 45 min. A further three 10 min washes were performed in 0.1 M sodium cacodylate buffer. Dehydration in graded concentrations of acetone (50 %, 70 %, 90 %, and 3 x 100 %) for 10 min each was followed by critical point drying using liquid CO2. After mounting on aluminium stubs with carbon tabs attached, the specimens were sputter coated with 20 nm gold palladium and viewed using a Hitachi S-4700 scanning electron microscope.
Inductively Coupled Plasma-Optical Emission spectrometry
The proportion of Pd element in the Pd-devices was determined by inductively coupled plasma-optical emission spectrometry at the School of Chemistry of the University of Edinburgh. A small amount of material (1-3 mg) was solubilized in a 10% HNO3 aqueous solution (1 mL) and heated at 80 °C overnight. The resulting mixture was diluted x5 in distilled water and Pd content measured in a Perkin
Elmer Optima 5300 DV ICP-OES spectrometer using commercial Pd sample as standard.
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4. Non-biological conversion assays
Non-biological Pd mediated activation of fluorogenic probe 3
Probe 3 was synthesised as previously reported [1] . Pd-devices (1 mg) were added to a 1 mL solution of reagent 3 (20 µM) in PBS supplemented with 10 % Fetal Bovine Serum (FBS). The mixtures were shaken at 1,200 rpm and 37°C in a thermomixer and reactions monitored at 6 h by fluorescence in a PerkinElmer Victor multilabel reader (excitation filter: 480nm; emissions filter: 535nm). The same conditions and reagents were used to test Pd-devices stored at 4 °C for 20 months.
Non-biological Pd mediated prodrug-into-drug conversion study
Stock sample of 2d (100 mM in DMSO) was diluted in PBS (1 mL) for a final concentration of 100 μM and incubated with 1 mg of 30 μm Pd-devices in a Thermomixer at 37 °C and 1200 rpm. 50 µL aliquots were removed at reported time intervals and monitored by analytical UPLC using a UV detector. Ultraperformance liquid chromatography (UPLC) was performed at Prof Alison Hulme's lab (School of Chemistry, University of Edinburgh) using a Waters Acquity UPLC PDA with a 50 x 2.4 mm Waters BEH C18 1.7 µm column, with compounds detected using an evaporative light scattering detector (ELSD) and UV detector.
Biological Methods
Cell culture
Cell lines were grown in culture media supplemented with 10 % Fetal Bovine Serum (FBS) and 2 mM L-glutamine, then incubated in a tissue culture incubator at 37 °C and 5 % CO2. Human prostate cancer DU145 cells (a gift from Prof Neil Carragher) and human glioblastoma multiforme U87 cells (a gift from Dr Noor Gamon) were cultured in Dulbecco's modified Eagle's media (DMEM).
Cytotoxicity study: drug vs prodrug
Cells were seeded in a 96 well plate format at 2000 cells/well and incubated for 48 h before treatment. well and the plate incubated for 1 h. Fluorescence emission was detected using a PerkinElmer Victor2 multilabel reader (Ex / Em: 540 nm / 590 nm). All conditions were normalized to control (100 %) and curves fitted with GraphPad Prism 5 using a sigmoidal variable slope curve.
Prodrug-into-drug conversion studies
Cells were plated as described and incubated for 48 h prior to treatment. Wells were then replaced with Zebrafish (AB line) were raised and maintained as previously described [2] . Embryos were generated by natural pair-wise mating and were kept and handled for all experiments in E3 medium (5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2, and 0.33 mM MgSO4). Manually dechorionated embryos were incubated between 24 hpf and 120 hpf 1 in E3 medium containing either 1 (Cambridge Biosciences) or prodrug 2d
at the following concentrations (50 μM, 100 μM, 150 μM and 200 μM). Embryos were soaked in DMSO (0.1 %) and E3 medium as a control. Embryos were kept in 6-well plates (15 embryos / well; 2 wells / condition) at 28.5 °C with dead embryos removed daily. Three experimental replicates were performed with n = 30 (15 x 2) embryos per condition and 2 replicates per condition. Pericardial edema and body surface was estimated using the area measurement tool in Fiji software. Results were obtained by randomly taking > 10 embryos per condition, then determining cardiac/body ratios as previously described [3] . Statistical analyses were performed using Prism GraphPad5 software. Data were subjected to an ordinary one-way ANOVA test. All pictures (fluorescent images included) were taken at the same resolution using an AZ100 upright macroscope (Nikon) with a Plan Apochromat 2 x / 0.45 lens equipped with a Retiga Exi camera (Qimaging) camera. Images were analyzed and processed with Micro-Manager, Fiji and GIMP softwares. Embryos were mounted laterally in 1.5 % Low Melting Point Agarose (Thermo Scientific) and kept in a 0.02 % w/v MS222 (Thermo scientific) solution in E3 medium and culled after imaging in an overdose of MS222 at the end of each experiment.
In vivo / ex vivo studies
All murine experiments were approved by the Animal Welfare and Ethical Review Board at the University of Glasgow and performed under the Home Office Project License 30/3185. The human prostate cancer cell line DU145 was purchased from ATCC, authenticated by LCG standards and grown in RPMI (Gibco) containing 10 % (v/v) serum supplement and 2 mM L-glutamine at a temperature of 37 C° with 5 % CO2. Nude athymic mice were purchased from XimBio. Mice were anesthetized by intraperitoneal injection of 0.5 mg / 1 g body weight NembutalR, 3 µL / 1 g body weight of
Ketamine/Xylazine/PBS mixture and subcutaneous morphine was administered subcutaneously at the injection site. The mouse was then placed in an induction chamber with 2 % isoflurane / 98 % oxygen and kept under anaesthesia through continuous nose cone flow during surgery. Mouse was positioned supine, and a midline incision provided access to the prostate gland. A 50 µL cell suspension containing 5 x 10 4 DU145 cells was injected into the prostate, and the round was appropriately closed with metal clips, before the mouse was transferred for recovering and monitoring.
In vivo intratumoural ultrasound-guided implantation of Pd-devices
Mice identified as having produced tumours from initial cancer cell culture implantation were anaesthetized as above and positioned supine on a mounted platform within a Visual Sonics Vevo 2100
Imaging Station. A solution of 1 mg of 30 µm Pd-devices in 25 µL was suspended in sterile PBS and injected into the mouse prostate using an insulin syringe/needle. Sterile surgical jelly was applied to the injection site, and the needle was appropriately positioned into the plane of ultrasound observation in the prostate tumour. Injection was completed over 30 s and was observed using the enhanced abdominal measurement package in the B-mode setting. Once the needle was removed, mice were transferred for recovery and monitoring.
Ex vivo catalytic studies
Mice were euthanized according to an IACUC approved method (CO2 asphyxiation) and an abdominal incision provided access to the prostate. Prostate tumours were excised with scissors, photographed, sliced longitudinally using a rate brain slicer instrument into 1 mm sections and affixed to the bottom of a 24 well plate using 1 -3 spots of tissue glue at the perimeter of each sample. Tumour slices were soaked in 2 mL of RPMI media containing 10 % (v/v) serum supplement and 2 mM L-glutamine, and 0.1 % (v/v) DMSO dissolving 100 μM of the corresponding reagent. 
